Market Value558,332,374
Total Holdings36
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PCVX / Vaxcyte, Inc.
VERA / Vera Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
GERN / Geron Corporation
RGEN / Repligen Corporation
RCKT / Rocket Pharmaceuticals, Inc.
KRYS / Krystal Biotech, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
ESTA / Establishment Labs Holdings Inc.
RLAY / Relay Therapeutics, Inc.
KALV / KalVista Pharmaceuticals, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
INSM / Insmed Incorporated
RVMD / Revolution Medicines, Inc.
BHVN / Biohaven Ltd.
DAWN / Day One Biopharmaceuticals, Inc.
GKOS / Glaukos Corporation
SPRY / ARS Pharmaceuticals, Inc.
NUVL / Nuvalent, Inc.
AXSM / Axsome Therapeutics, Inc.
BCAX / Bicara Therapeutics Inc.
APGE / Apogee Therapeutics, Inc.
EXAS / Exact Sciences Corporation
BPMC / Blueprint Medicines Corporation
NTRA / Natera, Inc.
ACLX / Arcellx, Inc.
ELVN / Enliven Therapeutics, Inc.
ADMA / ADMA Biologics, Inc.
MRUS / Merus N.V.
SNDX / Syndax Pharmaceuticals, Inc.
TMDX / TransMedics Group, Inc.
ITCI / Intra-Cellular Therapies, Inc.
ISRG / Intuitive Surgical, Inc.
CRMD / CorMedix Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S
XENE / Xenon Pharmaceuticals Inc.
MIRM / Mirum Pharmaceuticals, Inc.
JANX / Janux Therapeutics, Inc.
PRAX / Praxis Precision Medicines, Inc.
HQY / HealthEquity, Inc.
BBIO / BridgeBio Pharma, Inc.
HROW / Harrow, Inc.
CYTK / Cytokinetics, Incorporated
ARGX / argenx SE - Depositary Receipt (Common Stock)